InChI=1S/C22H31N3O5.H2O/c1- 2- 30- 22(29) 18(13- 12- 16- 8- 4- 3- 5- 9- 16) 23- 17- 10- 6- 14- 24- 15- 7- 11- 19(21(27) 28) 25(24) 20(17) 26;/h3- 5,8- 9,17- 19,23H,2,6- 7,10- 15H2,1H3,(H,27,28) ;1H2/t17- ,18- ,19- ;/m0./s1 |
JQRZBPFGBRIWSN-YOTVLOEGSA-N |
C1CC[C@@H](C(N2N1CCC[C@H]2C(=O)O)=O)N[C@H](C(OCC)=O)CCC3=CC=CC=C3.O |
|
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
An EC 3.4.15.* (peptidyl-dipeptidase) inhibitor that interferes with the action of peptidyl-dipeptidase A (EC 3.4.15.1).
|
|
antihypertensive agent
Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism.
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
An EC 3.4.15.* (peptidyl-dipeptidase) inhibitor that interferes with the action of peptidyl-dipeptidase A (EC 3.4.15.1).
prodrug
A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
|
|
View more via ChEBI Ontology
(1S,9S)- 9- {[(2S)- 1- ethoxy- 1- oxo- 4- phenylbutan- 2- yl]amino}- 10- oxooctahydro- 6H- pyridazino[1,2- a][1,2]diazepine- 1- carboxylic acid—water (1/1)
|
(1S,9S)- 9- {[(2S)- 1- ethoxy- 1- oxo- 4- phenylbutan- 2- yl]amino}- 10- oxooctahydro- 6H- pyridazino[1,2- a][1,2]diazepine- 1- carboxylic acid hydrate
|
IUPAC
|
cilazapril
|
ChemIDplus
|
cilazapril hydrate
|
KEGG DRUG
|
cilazapril.H2O
|
ChEBI
|
Ro 31-2848 monohydrate
|
ChemIDplus
|
Inhibace
|
KEGG DRUG
|
Justor
|
ChEBI
|
92077-78-6
|
CAS Registry Number
|
ChemIDplus
|
1836986
|
PubMed citation
|
Europe PMC
|
1839765
|
PubMed citation
|
Europe PMC
|
|